-
1
-
-
84872967522
-
Cancer statistics, 2013
-
Siegel R., Naishadham D., Jemal A. Cancer statistics, 2013. CA Cancer J Clin 2013, 63:11-30.
-
(2013)
CA Cancer J Clin
, vol.63
, pp. 11-30
-
-
Siegel, R.1
Naishadham, D.2
Jemal, A.3
-
2
-
-
84857658304
-
A critical analysis of the long-term impact of radical prostatectomy on cancer control and function outcomes
-
Boorjian S.A., Eastham J.A., Graefen M., et al. A critical analysis of the long-term impact of radical prostatectomy on cancer control and function outcomes. Eur Urol 2012, 61:664-675.
-
(2012)
Eur Urol
, vol.61
, pp. 664-675
-
-
Boorjian, S.A.1
Eastham, J.A.2
Graefen, M.3
-
3
-
-
79851513695
-
Predicting 15-year prostate cancer specific mortality after radical prostatectomy
-
Eggener S.E., Scardino P.T., Walsh P.C., et al. Predicting 15-year prostate cancer specific mortality after radical prostatectomy. J Urol 2011, 185:869-875.
-
(2011)
J Urol
, vol.185
, pp. 869-875
-
-
Eggener, S.E.1
Scardino, P.T.2
Walsh, P.C.3
-
4
-
-
84869085747
-
The impact of anatomical radical retropubic prostatectomy on cancer control: the 30-year anniversary
-
Mullins J.K., Feng Z., Trock B.J., Epstein J.I., Walsh P.C., Loeb S. The impact of anatomical radical retropubic prostatectomy on cancer control: the 30-year anniversary. J Urol 2012, 188:2219-2224.
-
(2012)
J Urol
, vol.188
, pp. 2219-2224
-
-
Mullins, J.K.1
Feng, Z.2
Trock, B.J.3
Epstein, J.I.4
Walsh, P.C.5
Loeb, S.6
-
5
-
-
84874512247
-
Impact of age and comorbidities on long-term survival of patients with high-risk prostate cancer treated with radical prostatectomy: a multi-institutional competing-risks analysis
-
Briganti A., Spahn M., Joniau S., et al. Impact of age and comorbidities on long-term survival of patients with high-risk prostate cancer treated with radical prostatectomy: a multi-institutional competing-risks analysis. Eur Urol 2013, 63:693-701.
-
(2013)
Eur Urol
, vol.63
, pp. 693-701
-
-
Briganti, A.1
Spahn, M.2
Joniau, S.3
-
6
-
-
79960596998
-
Long-term overall survival and metastasis-free survival for men with prostate-specific antigen-recurrent prostate cancer after prostatectomy: analysis of the Center for Prostate Disease Research National Database
-
Antonarakis E.S., Chen Y., Elsamanoudi S.I., et al. Long-term overall survival and metastasis-free survival for men with prostate-specific antigen-recurrent prostate cancer after prostatectomy: analysis of the Center for Prostate Disease Research National Database. BJU Int 2011, 108:378-385.
-
(2011)
BJU Int
, vol.108
, pp. 378-385
-
-
Antonarakis, E.S.1
Chen, Y.2
Elsamanoudi, S.I.3
-
7
-
-
83555166131
-
The natural history of metastatic progression in men with prostate-specific antigen recurrence after radical prostatectomy: long-term follow-up
-
Antonarakis E.S., Feng Z., Trock B.J., et al. The natural history of metastatic progression in men with prostate-specific antigen recurrence after radical prostatectomy: long-term follow-up. BJU Int 2012, 109:32-39.
-
(2012)
BJU Int
, vol.109
, pp. 32-39
-
-
Antonarakis, E.S.1
Feng, Z.2
Trock, B.J.3
-
8
-
-
22844434877
-
Risk of prostate cancer-specific mortality following biochemical recurrence after radical prostatectomy
-
Freedland S.J., Humphreys E.B., Mangold L.A., et al. Risk of prostate cancer-specific mortality following biochemical recurrence after radical prostatectomy. J Am Med Assoc 2005, 294:433-439.
-
(2005)
J Am Med Assoc
, vol.294
, pp. 433-439
-
-
Freedland, S.J.1
Humphreys, E.B.2
Mangold, L.A.3
-
9
-
-
0033526309
-
Natural history of progression after PSA elevation following radical prostatectomy
-
Pound C.R., Partin A.W., Eisenberger M.A., Chan D.W., Pearson J.D., Walsh P.C. Natural history of progression after PSA elevation following radical prostatectomy. J Am Med Assoc 1999, 281:1591-1597.
-
(1999)
J Am Med Assoc
, vol.281
, pp. 1591-1597
-
-
Pound, C.R.1
Partin, A.W.2
Eisenberger, M.A.3
Chan, D.W.4
Pearson, J.D.5
Walsh, P.C.6
-
10
-
-
0141919737
-
The long-term clinical impact of biochemical recurrence of prostate cancer 5 or more years after radical prostatectomy
-
Ward J.F., Blute M.L., Slezak J., Bergstralh E.J., Zincke H. The long-term clinical impact of biochemical recurrence of prostate cancer 5 or more years after radical prostatectomy. J Urol 2003, 170:1872-1876.
-
(2003)
J Urol
, vol.170
, pp. 1872-1876
-
-
Ward, J.F.1
Blute, M.L.2
Slezak, J.3
Bergstralh, E.J.4
Zincke, H.5
-
11
-
-
78650251130
-
A competing-risks analysis of survival after alternative treatment modalities for prostate cancer patients: 1988-2006
-
Abdollah F., Sun M., Thuret R., et al. A competing-risks analysis of survival after alternative treatment modalities for prostate cancer patients: 1988-2006. Eur Urol 2011, 59:88-95.
-
(2011)
Eur Urol
, vol.59
, pp. 88-95
-
-
Abdollah, F.1
Sun, M.2
Thuret, R.3
-
12
-
-
84878059899
-
Effect of age, tumor risk, and comorbidity on competing risks for survival in a U.S. population-based cohort of men with prostate cancer
-
Daskivich T.J., Fan K.H., Koyama T., et al. Effect of age, tumor risk, and comorbidity on competing risks for survival in a U.S. population-based cohort of men with prostate cancer. Ann Intern Med 2013, 158:709-717.
-
(2013)
Ann Intern Med
, vol.158
, pp. 709-717
-
-
Daskivich, T.J.1
Fan, K.H.2
Koyama, T.3
-
13
-
-
0032538069
-
Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer
-
D'Amico A.V., Whittington R., Malkowicz S.B., et al. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. J Am Med Assoc 1998, 280:969-974.
-
(1998)
J Am Med Assoc
, vol.280
, pp. 969-974
-
-
D'Amico, A.V.1
Whittington, R.2
Malkowicz, S.B.3
-
14
-
-
0023092594
-
A new method of classifying prognostic comorbidity in longitudinal studies: development and validation
-
Charlson M.E., Pompei P., Ales K.L., MacKenzie C.R. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chron Dis 1987, 40:373-383.
-
(1987)
J Chron Dis
, vol.40
, pp. 373-383
-
-
Charlson, M.E.1
Pompei, P.2
Ales, K.L.3
MacKenzie, C.R.4
-
15
-
-
0000120995
-
A class of K-sample tests for comparing the cumulative incidence of a competing risk
-
Gray R. A class of K-sample tests for comparing the cumulative incidence of a competing risk. Ann Stat 1988, 16:1140-1154.
-
(1988)
Ann Stat
, vol.16
, pp. 1140-1154
-
-
Gray, R.1
-
16
-
-
1542532754
-
A proportional hazards model for the subdistribution of a competing risk
-
Jason P.F., Gray R.J. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 1999, 94:496-509.
-
(1999)
J Am Stat Assoc
, vol.94
, pp. 496-509
-
-
Jason, P.F.1
Gray, R.J.2
-
17
-
-
0028224335
-
Hazard rate estimation under random censoring with varying kernels and bandwidths
-
Muller H.-G., Wang J.-L. Hazard rate estimation under random censoring with varying kernels and bandwidths. Biometrics 1994, 50:61-76.
-
(1994)
Biometrics
, vol.50
, pp. 61-76
-
-
Muller, H.-G.1
Wang, J.-L.2
-
18
-
-
25144458366
-
Radical prostatectomy: long-term cancer control and recovery of sexual and urinary function ("trifecta")
-
Bianco F.J., Scardino P.T., Eastham J.A. Radical prostatectomy: long-term cancer control and recovery of sexual and urinary function ("trifecta"). Urology 2005, 66(Suppl. 5):83-94.
-
(2005)
Urology
, vol.66
, pp. 83-94
-
-
Bianco, F.J.1
Scardino, P.T.2
Eastham, J.A.3
-
19
-
-
84897091488
-
Interval to biochemical recurrence following radical prostatectomy does not affect survival in men with low-risk prostate cancer
-
Bolton D.M., Ta A., Bagnato M., et al. Interval to biochemical recurrence following radical prostatectomy does not affect survival in men with low-risk prostate cancer. World J Urol 2014, 32:431-435.
-
(2014)
World J Urol
, vol.32
, pp. 431-435
-
-
Bolton, D.M.1
Ta, A.2
Bagnato, M.3
-
20
-
-
70349313376
-
Prostate cancer-specific mortality after radical prostatectomy for patients treated in the prostate-specific antigen era
-
Stephenson A.J., Kattan M.W., Eastham J.A., et al. Prostate cancer-specific mortality after radical prostatectomy for patients treated in the prostate-specific antigen era. J Clin Oncol 2009, 27:4300-4305.
-
(2009)
J Clin Oncol
, vol.27
, pp. 4300-4305
-
-
Stephenson, A.J.1
Kattan, M.W.2
Eastham, J.A.3
-
21
-
-
69249208647
-
Delayed prostate-specific antigen recurrence after radical prostatectomy: how to identify and what are their clinical outcomes?
-
Caire A.A., Sun L., Ode O., et al. Delayed prostate-specific antigen recurrence after radical prostatectomy: how to identify and what are their clinical outcomes?. Urology 2009, 74:643-647.
-
(2009)
Urology
, vol.74
, pp. 643-647
-
-
Caire, A.A.1
Sun, L.2
Ode, O.3
-
22
-
-
33748110792
-
Time to prostate specific antigen recurrence after radical prostatectomy and risk of prostate cancer specific mortality
-
Freedland S.J., Humphreys E.B., Mangold L.A., Eisenberger M., Partin A.W. Time to prostate specific antigen recurrence after radical prostatectomy and risk of prostate cancer specific mortality. J Urol 2006, 176(4 Pt 1):1404-1408.
-
(2006)
J Urol
, vol.176
, Issue.4
, pp. 1404-1408
-
-
Freedland, S.J.1
Humphreys, E.B.2
Mangold, L.A.3
Eisenberger, M.4
Partin, A.W.5
-
23
-
-
27244451002
-
Predictors of prostate cancer-specific mortality after radical prostatectomy or radiation therapy
-
Zhou P., Chen M.H., McLeod D., Carroll P.R., Moul J.W., D'Amico A.V. Predictors of prostate cancer-specific mortality after radical prostatectomy or radiation therapy. J Clin Oncol 2005, 23:6992-6998.
-
(2005)
J Clin Oncol
, vol.23
, pp. 6992-6998
-
-
Zhou, P.1
Chen, M.H.2
McLeod, D.3
Carroll, P.R.4
Moul, J.W.5
D'Amico, A.V.6
-
24
-
-
79955608101
-
Long-term risk of clinical progression after biochemical recurrence following radical prostatectomy: the impact of time from surgery to recurrence
-
Boorjian S.A., Thompson R.H., Tollefson M.K., et al. Long-term risk of clinical progression after biochemical recurrence following radical prostatectomy: the impact of time from surgery to recurrence. Eur Urol 2011, 59:893-899.
-
(2011)
Eur Urol
, vol.59
, pp. 893-899
-
-
Boorjian, S.A.1
Thompson, R.H.2
Tollefson, M.K.3
-
25
-
-
79960183335
-
Can we stop prostate specific antigen testing 10 years after radical prostatectomy?
-
Loeb S., Feng Z., Ross A., Trock B.J., Humphreys E.B., Walsh P.C. Can we stop prostate specific antigen testing 10 years after radical prostatectomy?. J Urol 2011, 186:500-505.
-
(2011)
J Urol
, vol.186
, pp. 500-505
-
-
Loeb, S.1
Feng, Z.2
Ross, A.3
Trock, B.J.4
Humphreys, E.B.5
Walsh, P.C.6
-
26
-
-
77956635392
-
Lifelong yearly prostate specific antigen surveillance is not necessary for low risk prostate cancer treated with radical prostatectomy
-
Tollefson M.K., Blute M.L., Rangel L.J., Karnes R.J., Frank I. Lifelong yearly prostate specific antigen surveillance is not necessary for low risk prostate cancer treated with radical prostatectomy. J Urol 2010, 184:925-929.
-
(2010)
J Urol
, vol.184
, pp. 925-929
-
-
Tollefson, M.K.1
Blute, M.L.2
Rangel, L.J.3
Karnes, R.J.4
Frank, I.5
-
27
-
-
84883772686
-
Survival following biochemical recurrence after radical prostatectomy and adjuvant radiotherapy in patients with prostate cancer: the impact of competing causes of mortality and patient stratification
-
Abdollah F., Boorjian S., Cozzarini C., et al. Survival following biochemical recurrence after radical prostatectomy and adjuvant radiotherapy in patients with prostate cancer: the impact of competing causes of mortality and patient stratification. Eur Urol 2013, 64:557-564.
-
(2013)
Eur Urol
, vol.64
, pp. 557-564
-
-
Abdollah, F.1
Boorjian, S.2
Cozzarini, C.3
-
28
-
-
0033935812
-
Long-term hazard of progression after radical prostatectomy for clinically localized prostate cancer: continued risk of biochemical failure after 5 years
-
Amling C.L., Blute M.L., Bergstralh E.J., Seay T.M., Slezak J., Zincke H. Long-term hazard of progression after radical prostatectomy for clinically localized prostate cancer: continued risk of biochemical failure after 5 years. J Urol 2000, 164:101-105.
-
(2000)
J Urol
, vol.164
, pp. 101-105
-
-
Amling, C.L.1
Blute, M.L.2
Bergstralh, E.J.3
Seay, T.M.4
Slezak, J.5
Zincke, H.6
-
29
-
-
84864475599
-
Early salvage radiation therapy does not compromise cancer control in patients with pT3N0 prostate cancer after radical prostatectomy: results of a match-controlled multi-institutional analysis
-
Briganti A., Wiegel T., Joniau S., et al. Early salvage radiation therapy does not compromise cancer control in patients with pT3N0 prostate cancer after radical prostatectomy: results of a match-controlled multi-institutional analysis. Eur Urol 2012, 62:472-487.
-
(2012)
Eur Urol
, vol.62
, pp. 472-487
-
-
Briganti, A.1
Wiegel, T.2
Joniau, S.3
-
30
-
-
84255162958
-
Gleason grading: past, present and future
-
Delahunt B., Miller R.J., Srigley J.R., Evans A.J., Samaratunga H. Gleason grading: past, present and future. Histopathology 2012, 60:75-86.
-
(2012)
Histopathology
, vol.60
, pp. 75-86
-
-
Delahunt, B.1
Miller, R.J.2
Srigley, J.R.3
Evans, A.J.4
Samaratunga, H.5
|